Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01638442 · ClinicalTrials.gov registry record · Phase 1
Crossover Trial of the Effect of a High-Fat Meal on the PK of Oral CHR 2797 in Healthy Male Subjects
A Phase 1 study, sponsored by CTI BioPharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT01638442: Completed Phase 1 study, sponsored by CTI BioPharma.
NCT01638442 is a Phase 1 study that has completed, run by CTI BioPharma. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01638442, a Phase 1 study, has completed, sponsored by CTI BioPharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
The objectives of this study are to evaluate the safety and tolerability; and to determine the effect of food on the pharmacokinetics (PK) of CHR-2797 in normal healthy male subjects.
Interventions
- DRUG CHR-2797
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2012-06 |
| Est. Completion | 2012-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01638442
The ClinicalTrials.gov registry entry for NCT01638442 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CTI BioPharma, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CHR-2797 is the first listed.
NCT01638442 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01638442 about?
NCT01638442 is a clinical study titled "Crossover Trial of the Effect of a High-Fat Meal on the PK of Oral CHR 2797 in Healthy Male Subjects". The objectives of this study are to evaluate the safety and tolerability; and to determine the effect of food on the pharmacokinetics (PK) of CHR-2797 in normal healthy male subjects.
What is the current status of trial NCT01638442?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2012-06. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01638442?
The interventions under investigation include: CHR-2797 (DRUG).
Who is sponsoring clinical trial NCT01638442?
This trial is sponsored by CTI BioPharma, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.